Understanding the Philips CPAP Recall
FDA Class I Recall, foam degradation, and lawsuit claims
2026 CPAP Recall Statistics
15M+
Devices Recalled
800K+
Lawsuits
$350,000
Avg Settlement
105K
FDA Reports
Injury Types & Avg Settlements
| Injury Type | Avg Settlement |
|---|---|
Lung Cancer Primary lung cancer diagnosis | $750,000 |
Other Cancers (Kidney, Liver) Kidney, liver, or other organ cancer | $600,000 |
Respiratory Illness COPD, asthma, breathing problems | $150,000 |
Headaches/Dizziness Chronic headaches, nausea, dizziness | $50,000 |
Organ Damage (Non-Cancer) Liver, kidney damage without cancer | $300,000 |
Wrongful Death Death from CPAP-related illness | $1,500,000 |
Recalled Devices
- • DreamStation: DreamStation 1, Auto, BiPAP
- • SystemOne: SystemOne Q-Series, REMstar
- • Trilogy Ventilator: Trilogy 100, 200
- • BiPAP A-Series: A30, A40
Usage Impact
- • Less than 1 year: 0.5x multiplier
- • 1-3 years: 0.8x multiplier
- • 3-5 years: 1x multiplier
- • 5-10 years: 1.3x multiplier
- • 10+ years: 1.5x multiplier
Advertisement
Based on FDA Class I Recall Notice, Philips Respironics Safety Communication 2021-2026, and MDL 3014 Court Filings